Some aspects of anti-inflammatory action of immunosuppressive drugs.
D000276:Adjuvants, Immunologic; D000818:Animals; D000893:Anti-Inflammatory Agents; D001168:Arthritis / Q000139:chemically induced / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001379:Azathioprine / Q000627:therapeutic use; D002351:Carrageenan; D003238:Connective Tissue / Q000187:drug effects; D003239:Connective Tissue Cells; D003520:Cyclophosphamide / Q000627:therapeutic use; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006854:Hydrocortisone / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009161:Mycobacterium / Q000276:immunology; D051381:Rats; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D002351:Carrageenan; D015122:Mercaptopurine; D001379:Azathioprine; D006854:Hydrocortisone; D008727:Methotrexate